ES2190727B1 - Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes. - Google Patents

Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes.

Info

Publication number
ES2190727B1
ES2190727B1 ES200101054A ES200101054A ES2190727B1 ES 2190727 B1 ES2190727 B1 ES 2190727B1 ES 200101054 A ES200101054 A ES 200101054A ES 200101054 A ES200101054 A ES 200101054A ES 2190727 B1 ES2190727 B1 ES 2190727B1
Authority
ES
Spain
Prior art keywords
cells
cell
increasing
relative number
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101054A
Other languages
English (en)
Other versions
ES2190727A1 (es
Inventor
Ilham Mohamed Saeed Abuljadayel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tristem Trading Cyprus Ltd
Original Assignee
Tristem Trading Cyprus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2190727(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/568,254 external-priority patent/US9068164B1/en
Priority claimed from GB0101315A external-priority patent/GB0101315D0/en
Priority claimed from GB0107093A external-priority patent/GB0107093D0/en
Application filed by Tristem Trading Cyprus Ltd filed Critical Tristem Trading Cyprus Ltd
Publication of ES2190727A1 publication Critical patent/ES2190727A1/es
Application granted granted Critical
Publication of ES2190727B1 publication Critical patent/ES2190727B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/12—Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
    • C12M41/14—Incubators; Climatic chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/04—Flat or tray type, drawers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/26—Constructional details, e.g. recesses, hinges flexible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/02—Stirrer or mobile mixing elements
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Dispositivo para formar y/o aumentar el número relativo de células indiferenciadas en una población celular, así como a un procedimiento para preparar una célula indiferenciada y a un procedimiento para aumentar el número relativo de dichas células. El cual dispositivo comprende medios para poner en contacto una célula más comprometida con un agente que provoca que la célula más comprometida se retrodiferencie a una célula indiferenciada. El procedimiento para preparar una célula indiferenciada comprende retrodiferenciar una célula más comprometida a una célula indiferenciada. La invención también comprende la utilización de los medios de retrodiferenciación para desplazar la proporción de células diferenciadas normales en una población celular, para llevar a cabo la retrodiferenciación de una o más de dichas células diferenciadas a una célula o células indiferenciadas.
ES200101054A 2000-05-10 2001-05-09 Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes. Expired - Fee Related ES2190727B1 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US09/568254 2000-05-10
US09/568,254 US9068164B1 (en) 1995-02-02 2000-05-10 Method of preparing an undifferentiated cell
GB0101315A GB0101315D0 (en) 2001-01-18 2001-01-18 A device
GB0101315 2001-01-18
US27149701P 2001-02-26 2001-02-26
US60/271497 2001-02-26
GB0107093A GB0107093D0 (en) 2001-03-21 2001-03-21 A device
GB0107093 2001-03-21

Publications (2)

Publication Number Publication Date
ES2190727A1 ES2190727A1 (es) 2003-08-01
ES2190727B1 true ES2190727B1 (es) 2004-09-01

Family

ID=27447916

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200101054A Expired - Fee Related ES2190727B1 (es) 2000-05-10 2001-05-09 Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes.
ES01929796T Expired - Lifetime ES2330190T3 (es) 2000-05-10 2001-05-10 Dispositivo para la preparacion de celulas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01929796T Expired - Lifetime ES2330190T3 (es) 2000-05-10 2001-05-10 Dispositivo para la preparacion de celulas.

Country Status (27)

Country Link
US (1) US8163536B2 (es)
EP (1) EP1366144B1 (es)
JP (2) JP4860883B2 (es)
KR (2) KR100875089B1 (es)
AR (1) AR030280A1 (es)
AT (1) ATE440944T1 (es)
AU (1) AU5647701A (es)
BE (1) BE1014172A3 (es)
BR (2) BR0110751A (es)
CA (2) CA2446955C (es)
CH (1) CH696146B9 (es)
CY (1) CY1109515T1 (es)
DE (1) DE60139716D1 (es)
DK (1) DK1366144T3 (es)
ES (2) ES2190727B1 (es)
FR (1) FR2808800B1 (es)
GB (2) GB2366295B (es)
HK (2) HK1044172A1 (es)
IL (2) IL152737A0 (es)
IT (1) ITMI20010952A1 (es)
JO (1) JO2295B1 (es)
MA (1) MA25677A1 (es)
MX (1) MXPA02012295A (es)
NL (1) NL1017973C2 (es)
NZ (2) NZ556592A (es)
SA (1) SA01220163B1 (es)
WO (1) WO2001085917A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946246B1 (en) * 1997-04-08 2005-09-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Production of functional proteins: balance of shear stress and gravity
US7565647B2 (en) * 2002-03-22 2009-07-21 Sun Microsystems, Inc. Markup compiler that outputs MIDlets
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
DE10231655A1 (de) * 2002-07-12 2004-02-26 Blasticon Biotechnologische Forschung Gmbh Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung
WO2004011049A1 (ja) * 2002-07-25 2004-02-05 Japan Science And Technology Agency 生体組織材料を処理する交互浸漬装置および交互浸漬方法
PL379549A1 (pl) * 2003-07-11 2006-10-16 Blasticon Biotechnologische Forschung Gmbh Autologiczne, indukujące tolerancję na antygeny własne komórki pochodzenia monocytarnego oraz ich zastosowanie w preparatach farmaceutycznych
GB0410130D0 (en) * 2004-05-06 2004-06-09 Molmed Spa Cell preparation
WO2005113754A1 (en) * 2004-05-20 2005-12-01 New York Medical College Pluripotent adult stem cells
US7147626B2 (en) * 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
US7909806B2 (en) * 2004-09-23 2011-03-22 Anthrogenesis Corporation Cord blood and placenta collection kit
AU2006286149B2 (en) 2005-08-29 2012-09-13 Technion Research And Development Foundation Ltd. Media for culturing stem cells
CA2644922C (en) 2006-03-07 2019-07-23 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US9040297B2 (en) 2006-08-02 2015-05-26 Technion Research & Development Foundation Limited Methods of expanding embryonic stem cells in a suspension culture
AR065584A1 (es) * 2007-03-01 2009-06-17 Cryo Cell Internat Inc Obtencion aislamiento y crioconservacion de celulas endometriales / menstruales
GB0917565D0 (en) * 2009-10-08 2009-11-25 Univ Nottingham An observation cell arrangement
GB2474492B (en) * 2009-10-19 2014-05-21 Tristem Trading Cyprus Ltd Treatment using reprogrammed mature adult cells
ES2932664T3 (es) 2009-11-12 2023-01-23 Technion Res & Dev Foundation Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado
EP2639294A1 (fr) * 2012-03-15 2013-09-18 CellProthera Automate et procédé automatisé de culture cellulaire
CA2927712A1 (en) 2013-10-24 2015-04-30 Ospedale San Raffaele S.R.L. Method for the genetic modification of haematopoietic stem and progenitor cells (hspcs) and the use of genetically modified hspcs in gene therapy
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
WO2017202949A1 (en) 2016-05-25 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating cancers
US10711237B2 (en) * 2017-08-22 2020-07-14 Idex Health & Science Llc Apparatus and methods for bioprocesses and other processes
CA3083158A1 (en) 2017-11-24 2019-05-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and compositions for treating cancers
CN108889357A (zh) * 2018-05-10 2018-11-27 刘英文 一种检验科样品临时存储装置
EP3833383A1 (en) 2018-08-06 2021-06-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating cancers
CN111560345A (zh) * 2019-05-10 2020-08-21 华中科技大学同济医学院附属协和医院 一种猪原代瓣膜内皮细胞分离纯化方法
WO2022207889A1 (en) 2021-04-01 2022-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058367A (en) * 1976-05-19 1977-11-15 Gilford Instrument Laboratories Inc. Automatic asynchronous fluid processing apparatus
US4563907A (en) * 1983-10-31 1986-01-14 Micromedic Systems Inc. Direct reading automatic pipette
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
JPS63196854A (ja) * 1987-02-10 1988-08-15 Toa Medical Electronics Co Ltd リンパ球亜群の測定方法およびその装置
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5635387A (en) * 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
EP0626067A4 (en) * 1992-02-07 1997-06-25 Abbott Lab METHOD FOR ACCURATELY COUNTING AND SENSITIVELY CLASSIFYING HETEROGENEOUS CELL POPULATIONS UNDER CYTOLYTIC PROCESSING CONDITIONS.
KR100271284B1 (ko) * 1992-03-04 2000-11-01 로버트 엘. 로브 사람의 스템 세포 및/또는 조혈세포를 유지하고 증식시키는 방법, 조성 및 장치
WO1996002255A1 (fr) * 1994-07-15 1996-02-01 Taiyo Kagaku Co., Ltd. Composition medicamenteuse contenant un derive d'acide sialique
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
JPH10513054A (ja) * 1995-02-02 1998-12-15 ステイヒテイング・セントラール・ラボラトリウム・バン・デ・ブレドトランスフシーデイーンスト・バン・ヘト・ネーデルランドセ・ロデ・クルイス 血液もしくは骨髄からの造血幹細胞の濃縮
GB2297558B (en) * 1995-02-02 1997-01-08 Ilham Mohamed Sale Abuljadayel Conversion of a more committed cell to an undifferentiated cell
US5627070A (en) * 1995-07-26 1997-05-06 Celltherapy, Inc. Cell growing device for in vitro cell population expansion
US5902732A (en) * 1995-10-04 1999-05-11 Cytoscan Sciences Llc Drug screening process measuring changes in cell volume
US6227202B1 (en) 1996-09-03 2001-05-08 Maulana Azad Medical College Method of organogenesis and tissue regeneration/repair using surgical techniques
NZ334976A (en) * 1996-11-11 2000-10-27 Byk Gulden Lomberg Chem Fab Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses
AU6691798A (en) * 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
FR2771421B1 (fr) * 1997-11-27 2001-05-04 Bertin & Cie Dispositif d'amplification de cellules hematopoietiques et ses applications
EP1332673B1 (en) * 1998-02-17 2012-05-30 Gamida Cell Ltd. Method of controlling proliferation and differentiation of stem and progenitor cells
BR9914465A (pt) * 1998-09-29 2001-10-09 Gamida Cell Ltd Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
EP2311938B1 (en) * 1999-02-04 2016-04-06 Pluristem Ltd. Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
EP1159443A1 (de) * 1999-03-09 2001-12-05 Acordis Industrial Fibers GmbH Verfahren zum in vitro testen von wirkstoffen, vorrichtung und deren verwendung
FR2794130B1 (fr) * 1999-05-26 2003-01-03 Bertin Technologies Sa Procede et dispositif de culture de cellules a applications multiples
JP2003528577A (ja) * 1999-07-29 2003-09-30 バラノヴィッツ，スティーブン 身体組織の分化転換方法
US6624621B2 (en) * 2000-04-03 2003-09-23 Howard L. North, Jr. Particle counter volume sensor

Also Published As

Publication number Publication date
ATE440944T1 (de) 2009-09-15
US20030064503A1 (en) 2003-04-03
GB0111488D0 (en) 2001-07-04
AU5647701A (en) 2001-11-20
ITMI20010952A1 (it) 2002-11-10
JP2004515211A (ja) 2004-05-27
CH696146B9 (fr) 2009-06-15
JP4860883B2 (ja) 2012-01-25
BRPI0110751B1 (pt) 2019-10-01
GB2375351B (en) 2003-11-26
CA2776904A1 (en) 2001-11-15
MA25677A1 (fr) 2003-04-01
WO2001085917A2 (en) 2001-11-15
KR100967071B1 (ko) 2010-07-01
GB2366295A (en) 2002-03-06
KR20030034069A (ko) 2003-05-01
GB2375351A (en) 2002-11-13
AR030280A1 (es) 2003-08-20
FR2808800A1 (fr) 2001-11-16
CA2446955C (en) 2012-07-17
BE1014172A3 (fr) 2003-06-03
SA01220163B1 (ar) 2007-04-24
NZ540481A (en) 2009-02-28
GB2366295B (en) 2003-09-10
MXPA02012295A (es) 2004-08-12
FR2808800B1 (fr) 2007-07-06
KR100875089B1 (ko) 2008-12-22
ES2190727A1 (es) 2003-08-01
KR20070103522A (ko) 2007-10-23
ITMI20010952A0 (it) 2001-05-10
DK1366144T3 (da) 2009-12-21
CH696146A5 (fr) 2007-01-15
CA2446955A1 (en) 2001-11-15
EP1366144A2 (en) 2003-12-03
BR0110751A (pt) 2004-04-06
IL152737A (en) 2010-11-30
CY1109515T1 (el) 2014-08-13
HK1044172A1 (zh) 2002-10-11
ES2330190T3 (es) 2009-12-07
NL1017973C2 (nl) 2002-11-08
GB0215519D0 (en) 2002-08-14
EP1366144B1 (en) 2009-08-26
NL1017973A1 (nl) 2001-11-13
HK1091860A1 (en) 2007-01-26
WO2001085917A3 (en) 2003-10-09
JP2011155984A (ja) 2011-08-18
IL152737A0 (en) 2003-07-06
JO2295B1 (en) 2005-09-12
NZ556592A (en) 2011-03-31
DE60139716D1 (de) 2009-10-08
US8163536B2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
ES2190727B1 (es) Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes.
SE9900519D0 (sv) A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
ECSP066461A (es) Método para activar las poblaciones de célula especificas utilizando conjugados maitansinoides del agente de enlace celular enlazados a través de un enlazador no divisible, dichos conjugados, y métodos para hacer dichos conjugados
CO5271708A1 (es) Ensayo y metodos basados en el uso de canales de sodio como objetivos de amiloide b o de sus agregados
DK1272616T3 (da) Humane, pancreatiske, epitelstamfaderceller og fremgangsmåder til isolation og anvendelse deraf
BR0308629A (pt) Sistema de comunicação, nó de comunicação para uso no mesmo, e, método de comunicação
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
AR040302A1 (es) Dispositivos para la liberacion transdermica de farmacos, que presentan microprotrusiones recubiertas
BR0215405A (pt) Composições e processos de uso de collajolie
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
DE50306238D1 (de) Strukturierter Körper für eine in Brennstoffzellen verwendete Anode
NL1021701A1 (nl) PEM-brandstofcel.
AR023736A1 (es) Ensayo de viabilidad para protozoarios formadores de esporocitos
ITRM20020529A1 (it) Polimeri sterilizzanti, processo di loro preparazione ed uso.
CA107231S (en) Electrochemical test strip
ES2157690T3 (es) Metodo de producir el nivel de potencia recibido en una estacion base de una red cdma y estacion base para su ejecucion.
DE502004009943D1 (de) Hohlspitzgeschoss
BR0116058B1 (pt) dispositivo de retenção para um modelo de prótese dentária ou modelo de armação básica.
NO20012100D0 (no) Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelse
CL2004001767A1 (es) Metodo para el recrecimiento de celulas embriogenicas de coniferas criopreservadas que comprende contactar dichas celulas con un medio de transicion liquido, como paso previo al de contactarlas con el medio de recrecimiento, y donde ambos medios cont
AR038849A1 (es) Uso de ribozimas en la deteccion de agentes adventicios
DE60334533D1 (de) Gewebe-engineering
ES2167080T3 (es) Instrumento de medicion.
MXPA03011009A (es) Metodos para mejorar la actividad de lineas celulares en dispositivos de inmunoaislamiento.
PA8594001A1 (es) Metodo de proteccion dermica

Legal Events

Date Code Title Description
PC2A Transfer of patent
EC2A Search report published

Date of ref document: 20030801

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2190727B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211119